SUMMIT
Research Project |
|
A multi-part, randomized, double-blind, placebo-controlled phase 2 clinical study of the safety and efficacy of bezuclastinib in subjects with nonadvanced systemic mastocytosis
A multi-part, randomized, double-blind, placebo-controlled phase 2 clinical study of the safety and efficacy of bezuclastinib in subjects with nonadvanced systemic mastocytosis